Company/Division name | Enable Injections, Inc.? |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Total number of jobs (added or to be added): | 450 |
Year reshoring announced: | 2024 |
Domestically, the work will be done: | In-house |
City reshored to: | Springdale |
State(s) reshored to: | OH |
If relevant, work nearshored to: | - |
Industry(ies): | Medical Equipment & Supplies |
Product(s) reshored | enFuse®?platform of wearable technology |
What domestic positive factors made reshoring more attractive? | Higher productivity, Lead time/Time to market |